PARAMETRIC PORTFOLIO ASSOCIATES LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$130,000
-9.7%
55,993
+10.5%
0.00%
Q4 2017$144,000
+82.3%
50,684
+83.9%
0.00%
Q3 2017$79,000
+203.8%
27,562
+157.5%
0.00%
Q2 2017$26,000
-89.1%
10,704
-83.8%
0.00%
Q1 2017$238,000
+4.4%
65,884
+2.2%
0.00%
Q4 2016$228,000
+230.4%
64,475
+278.3%
0.00%
Q3 2016$69,000
-79.2%
17,042
-77.4%
0.00%
-100.0%
Q2 2016$331,000
+353.4%
75,450
+288.4%
0.00%
Q1 2016$73,000
-81.9%
19,425
-24.7%
0.00%
-100.0%
Q4 2015$404,000
+39.3%
25,796
-6.1%
0.00%0.0%
Q3 2015$290,000
-77.4%
27,479
-45.9%
0.00%
-66.7%
Q2 2015$1,282,000
-13.4%
50,817
-4.3%
0.00%0.0%
Q1 2015$1,480,000
+59.8%
53,086
+4.6%
0.00%
+50.0%
Q4 2014$926,000
+84.1%
50,733
+30.6%
0.00%
+100.0%
Q3 2014$503,000
+50.1%
38,849
+89.1%
0.00%0.0%
Q2 2014$335,000
-0.3%
20,543
+8.1%
0.00%0.0%
Q1 2014$336,000
-37.9%
18,996
-14.9%
0.00%0.0%
Q4 2013$541,000
+13.7%
22,328
+66.1%
0.00%0.0%
Q3 2013$476,000
+121.4%
13,444
-2.2%
0.00%0.0%
Q2 2013$215,00013,7420.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,000$3,096,000100.00%
TSP Capital Management Group, LLC 698,674$1,549,0000.79%
Meditor Group Ltd 6,312,700$2,847,0000.61%
Telemetry Investments, L.L.C. 186,200$84,0000.04%
GSA CAPITAL PARTNERS LLP 1,270,500$573,0000.03%
Benchmark Capital Advisors 53,400$24,0000.02%
BOENNING & SCATTERGOOD, INC. 80,150$36,0000.01%
NJ State Employees Deferred Compensation Plan 80,000$36,0000.01%
Centiva Capital, LP 121,720$55,0000.01%
Overbrook Management Corp 48,611$22,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders